Skip to the page

Data / Drug companies / Oxazepam

Oxazepam: 6 companies and 16 products in the FDA NDC directory

Oxazepam is listed in the FDA National Drug Code Directory by 6 companies, with 16 products in commercial distribution. 16 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; capsule, gelatin coated, and the newest product started marketing on July 9, 2025.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
6
Products
16
Generic (ANDA) products
16 (100.0%)
Application numbers
4
Controlled substance schedule
Schedule IV
Routes
Oral
openFDA record search
api.fda.gov

Companies that list oxazepam

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Actavis Pharma, Inc.3capsule, gelatin coatedGeneric drugs (ANDA)January 2, 2007
American Health Packaging3capsule, gelatin coatedGeneric drugs (ANDA)December 17, 2007
Epic Pharma, LLC3capsuleGeneric drugs (ANDA)April 19, 1988
Leading Pharma, LLC3capsuleGeneric drugs (ANDA)July 9, 2025
TruPharma, LLC3capsuleGeneric drugs (ANDA)June 1, 2021
Aphena Pharma Solutions - Tennessee, LLC1capsuleGeneric drugs (ANDA)June 1, 2021

Dosage forms

Dosage formProductsShare
Capsule1062.5%
Capsule, gelatin coated637.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)16100%

Pharmacologic classes

ClassProducts
Benzodiazepine16

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.